{
    "eid": "2-s2.0-85087722050",
    "title": "Long-term patient-rated cosmetic and satisfactory outcomes of early breast cancer treated with conventional versus hypofractionated breast irradiation with simultaneous integrated boost technique",
    "cover-date": "2020-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Internal Medicine",
            "@code": "2724",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Surgery",
            "@code": "2746",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "breast cancer",
        "cosmesis",
        "hypofractionation",
        "satisfaction",
        "simultaneous integrated boost"
    ],
    "authors": [
        "Chawalit Lertbutsayanukul",
        "Manida Pitak",
        "Natthagorn Ajchariyasongkram",
        "Nichakon Rakkiet",
        "Farinda Seuree",
        "Anussara Prayongrat"
    ],
    "citedby-count": 7,
    "ref-count": 38,
    "ref-list": [
        "Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer",
        "Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial",
        "The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial",
        "Long-term results of hypofractionated radiation therapy for breast cancer",
        "The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial",
        "The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial",
        "The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials",
        "Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial",
        "Hypofractionation should be the new 'standard' for radiation therapy after breast conserving surgery",
        "A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma",
        "Late effects and cosmetic results of simultaneous integrated boost versus sequential boost after conventional irradiation in breast-conserving therapy; out come of 7 months follow-up",
        "Skin toxicity and cosmesis after hypofractionated whole breast irradiation for early breast cancer",
        "Evaluation of breast conserving therapy: clinical, methodological and psychosocial perspectives",
        "Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up",
        "Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessments",
        "Quantitative assessment of breast cosmetic outcome after whole-breast irradiation",
        "Cosmetic outcome assessment following breast-conserving therapy: a comparison between BCCT.core Software and panel evaluation",
        "Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer",
        "Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients",
        "Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results",
        "Prone breast intensity modulated radiation therapy: 5-year results",
        "Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy\u2013a feasibility and toxicity study",
        "Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue",
        "Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phase II trial (ARO-2010-01)",
        "Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer",
        "Comparison of acute and late toxicity of two regimens of 3- and 5-week concomitant boost prone IMRT to standard 6-week breast radiotherapy",
        "Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial",
        "Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients",
        "Three-year outcomes with hypofractionated versus conventionally fractionated whole-breast irradiation: Results of a randomized, noninferiority clinical trial",
        "Accelerated fractionation with a concurrent boost for early stage breast cancer",
        "Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial",
        "Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives",
        "Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity",
        "Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost",
        "Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial",
        "Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): first results of a prospective multicenter trial (NCT01343459)",
        "Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}